Executive Summary


  • Reports Revenue YTD of €1.28 million, expecting more than 60% growth for the full year 2017
  • Reports EBITDA YTD of €355 k, +802 thousand euros compared to the full year 2016
  • Reports the executions of an exclusive license agreement for the development, registration, manufacturing, and commercialization of BNT005 in Argentina and Paraguay.
  • Reports the signing of an Evaluation and Licensing agreement with exclusive worldwide license rights (except in Argentina and Paraguay) for the development, registration and commercialization of BNT005 with a top leading company in the sector
  • Reports ZIP patents granted in USA, EUROPE and JAPAN
  • Reports reaching an E&O agreement with a global leader for the exclusive development, registration and marketing of a probiotic for oral application, indicated to improve oral health in companion animals
  • Reports the signing by Biobide of new relevant contracts with three leading companies in the agrochemical and biomedicine sectors, for a cumulative amount worth of USD 1.39 million
  • Reports BNT005 patent granted in CHINA.

 

Click here to see the official document. (only spanish)